Beste apotheek van Nederland

Marks L S, Duda C, Dorey F J et al. Treatment of erectile
dysfunction with sildenafil.[see comment]. Urology
1999;53(1):19-24.
Marshall G A, Breza J, Lue T F. Improved hemodynamic
response after long-term intracavernous injection for impotence.
Urology 1994;43(6):844-848.
Martin-Morales A, Haro J M, Beardsworth A et al. Therapeutic
effectiveness and patient satisfaction after 6 months of treatment
with tadalafil, sildenafil, and vardenafil: results from the erectile
dysfunction observational study (EDOS). Eur Urol
2007;51(2):541-550.
Martin-Morales A, Moncada Iribarren I, Cruz Navarro N et al.
[Efficacy and safety of two dosing regimens with Tadalafil in
Spanish men with erectile dysfunction: results from the SURE
study in 14 European countries]. Actas Urol Esp
2006;30(8):791-800.
Martinez R, Puigvert A, Pomerol J M et al. Clinical experience
with apomorphine hydrochloride: the first 107 patients. Br J
Urol 2003;170(6:Pt 1):t-5.
Martinez-Jabaloyas J M, Gil-Salom M, Villamon-Fort R et al.
Prognostic factors for response to sildenafil in patients with
erectile dysfunction. Eur Urol 2001;40(6):641-647.
Martinez-Pineiro L, Cortes R, Cuervo E et al. Prospective
comparative study with intracavernous sodium nitroprusside and
prostaglandin E1 in patients with erectile dysfunction. Eur Urol
1998;34(4):350-354.
Matthew A G, Goldman A, Trachtenberg J et al. Sexual
dysfunction after radical prostatectomy: Prevalence, treatments,
restricted use of treatments and distress. Br J Urol
2005;174(6):2105-2110.
Maytom M C, Derry F A, Dinsmore W W et al. A two-part pilot
study of sildenafil (VIAGRA) in men with erectile dysfunction
caused by spinal cord injury. Spinal Cord. 1999;37(2):110-116.
McClure R D. Endocrine evaluation and therapy of erectile
dysfunction. [Review] [77 refs]. Urol Clin North Am
1988;15(1):53-64.
McClure R D, Oses R, Ernest M L. Hypogonadal impotence
treated by transdermal testosterone. Urology 1991;37(3):224­
228.
McConnell J D, Roehrborn C G, Bautista O M et al. The Long-
Term Effect of Doxazosin, Finasteride, and Combination
Therapy on the Clinical Progression of Benign Prostatic
Hyperplasia. N Engl J Med 2003;349(25):2387-2398.
McCullough A R, Barada J H, Fawzy A et al. Achieving
treatment optimization with sildenafil citrate (Viagra) in patients
with erectile dysfunction. Urology 2002;60(2 Suppl 2):28-38.
McCullough A R, Carson C C, Hatzichristou D. A
prospective study of the beneficial effects of dose
optimization and customized instructions on patient
satisfaction with sildenafil citrate (Viagra) for erectile
dysfunction. Urology 2006;68(3 Suppl):38-46.
McMahon C. Comparison of erectile responses to
differing doses of prostaglandin PGE1 in an attempt to
standardise pharmacological diagnosis of impotence.
Journal of Assisted Reproduction & Genetics
1992;9265A
McMahon C. Efficacy and safety of daily tadalafil in
men with erectile dysfunction previously unresponsive
to on-demand tadalafil. Br J Sex Med 2004;1(3):292­
300.
McMahon C G. High dose sildenafil citrate as a
salvage therapy for severe erectile dysfunction. Int J
Impot Res 2002;14(6):533-538.
McMahon C G. An attempt to standardize the
pharmacological diagnostic screening of vasculogenic
impotence with prostaglandin E1. Int J Impot Res
1995;7(2):83-90.
McMahon C G. Topiglan: MacroChem. Curr Opin
Investig Drugs 2002;3(4):602-606.
McMahon C G. A pilot study of the role of
intracavernous injection of vasoactive intestinal
peptide (VIP) and phentolamine mesylate in the
treatment of erectile dysfunction. Int J Impot Res
1996;8(4):233-236.
McMahon C G. Priapism associated with concurrent
use of phosphodiesterase inhibitor drugs and
intracavernous injection therapy. Int J Impot Res
2003;15(5):383-384.
McMahon C G, Samali R, Johnson H. Efficacy, safety
and patient acceptance of sildenafil citrate as treatment
for erectile dysfunction. Br J Urol 2000;164(4):1192­
1196.
McMahon C G, Samali R, Johnson H. Treatment of
intracorporeal injection nonresponse with sildenafil
alone or in combination with triple agent
intracorporeal injection therapy. Br J Urol
1997;162(6):1992-1997.
McMahon C, Lording D, Stuckey B et al. Vardenafil
improved erectile function in a "real-life" broad
population study of men with moderate to severe
erectile dysfunction in Australia and New Zealand. Br
J Sex Med 2006;3(5):892-900.
McVary K T, Polepalle S, Riggi S et al. Topical
prostaglandin E1 SEPA gel for the treatment of
erectile dysfunction.. Br J Urol 1999;162(3 Pt 1):732
D-174